VasoCARE

FSS Contract # 36F79726D0055

(January 15, 2026 – January 14, 2031)

Dear VA Hospitals and Outpatient Clinics:

VasoCARE is proud to announce the VA has awarded VasoCARE an FSS contract that covers the Legacy^® IPC, a new transformational device proven to prevent Deep Vein Thrombosis (DVT) from developing during hospital stay and while recovering at home.

The Legacy^® IPC is a single-patient wearable device proven to prevent the formation of clots from developing by inflating the Comfort Sleeves every minute for 12-15 seconds at 45 mmHg. Legacy^® is the first wearable device that operates in total silence which promotes quality rest and sleep.

The transformational Legacy Pump with Comfort Sleeve weighs only 5 ounces, promotes mobility, and is proven to prevent clots from developing.

In a major hospital trial involving 280 patients for 4 months, Legacy^® IPC showed patient compliance exceeded 85%, daily wear time above 18 hours, and 0% hospital-acquired DVTs.

Besides preventing DVT, the Legacy^® IPC helps prevents Post Thrombotic Syndrome (PTS), a chronic vascular condition that leads to chronic edema, swelling, skin breakdown, and eventually Venous Stasis Ulcers. Past studies have shown how chronic pain and open wounds involving PTS and VSU had directly led to Veterans committing suicide.

Our goal is to prevent DVT during hospital stay or while recovering at home for Veterans considered high-risk after undergoing joint replacement, spine, and/or major abdominal surgery.

Ordering the Legacy^® IPC Device System: